Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Innovative Skincare Clinical presents study results and product evaluations to help you assess effectiveness and safety in modern skincare.
1,166 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
A century-and-a-half-old Indiana company is drawing fresh investor attention with a plan to become the world's larges...
Novocure faces a pivotal year as TTFields therapy expands and reimbursement pathways evolve. This guide breaks down w...
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
When a biotech company’s leader sells shares, it can raise questions for investors. This guide breaks down how to int...
As investors digest Organogenesis (Orgo) 2025 earnings, the focus shifts to revenue mix, profitability, and upcoming ...
Insider moves can shed light on a company’s trajectory, but they aren’t a crystal ball. This guide breaks down biotec...
A wrist-worn hormone monitor backed by a $11 million seed round aims to turn hormone tracking into everyday wellness....
Eli Lilly is delivering big news for investors. The rallying force behind recent gains comes from GLP-1 drugs, manufa...
A high-profile fund sold a sizable GRAIL stake right before a dramatic 50% one-day drop. This article unpacks the mov...
A biotech name drops sharply after mixed obesity data, sending Wave Life Sciences and the broader market into a brief...